Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • Qiagen's Cash & Current Investments fell 468.99% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year decrease of 468.99%. This contributed to the annual value of $1.1 billion for FY2025, which is 468.99% down from last year.
  • Latest data reveals that Qiagen reported Cash & Current Investments of $1.1 billion as of Q4 2025, which was down 468.99% from $1.7 billion recorded in Q3 2025.
  • In the past 5 years, Qiagen's Cash & Current Investments registered a high of $1.9 billion during Q3 2022, and its lowest value of $3.9 million during Q1 2021.
  • For the 5-year period, Qiagen's Cash & Current Investments averaged around $1.1 billion, with its median value being $1.1 billion (2021).
  • Its Cash & Current Investments has fluctuated over the past 5 years, first tumbled by 9550.9% in 2021, then skyrocketed by 3106573.75% in 2022.
  • Qiagen's Cash & Current Investments (Quarter) stood at $1.1 billion in 2021, then soared by 33.21% to $1.4 billion in 2022, then decreased by 25.42% to $1.1 billion in 2023, then rose by 9.0% to $1.2 billion in 2024, then decreased by 4.69% to $1.1 billion in 2025.
  • Its Cash & Current Investments stands at $1.1 billion for Q4 2025, versus $1.7 billion for Q3 2025 and $953.8 million for Q2 2025.